Medical Disclaimer: This information is educational only and does not constitute medical advice. Cannabis affects everyone differently. Always consult a qualified healthcare provider before using cannabis, especially if you take other medications. Never discontinue prescribed medications without medical supervision.

Overview

Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. It affects approximately 3.4 million people in the United States alone, and while many patients achieve seizure control with conventional anti-seizure medications, roughly one-third have drug-resistant epilepsy — their seizures do not respond adequately to two or more medications tried at appropriate doses.

For these patients, and particularly for children with severe epilepsy syndromes, the search for effective treatments is urgent. This is where cannabis — specifically purified CBD — has made its most significant, most rigorously demonstrated impact.

Conventional epilepsy treatments include anti-seizure medications (such as valproate, levetiracetam, lamotrigine, and clobazam), dietary therapies like the ketogenic diet, vagus nerve stimulation, and in some cases, brain surgery. These treatments can be life-changing, but for patients with treatment-resistant forms, options have historically been limited.

What the Research Says

This is the area where cannabis medicine has its strongest footing. The evidence is not preliminary or anecdotal — it includes the kind of large-scale, randomized, placebo-controlled clinical trials that represent the gold standard of medical evidence.

Epidiolex: The FDA-Approved CBD Medication

Epidiolex (purified CBD) is FDA-approved and has changed the treatment landscape for severe pediatric seizure disorders. This represents some of the most rigorous clinical evidence in all of cannabis medicine.
TryCannabis.org Research Report, 2026

In 2018, the FDA approved Epidiolex (cannabidiol oral solution), a purified form of CBD derived from the cannabis plant, for the treatment of seizures associated with two severe forms of epilepsy:

Dravet syndrome — a rare genetic epilepsy that begins in infancy and causes frequent, prolonged seizures that are extremely difficult to control. It is associated with developmental delays and a high risk of sudden unexpected death in epilepsy (SUDEP).
Lennox-Gastaut syndrome (LGS) — a severe form of childhood-onset epilepsy characterized by multiple seizure types, cognitive impairment, and an abnormal brain wave pattern. Most patients have seizures that resist conventional medications.

The FDA subsequently expanded Epidiolex's approval to include seizures associated with tuberous sclerosis complex (TSC), another condition where seizures are often treatment-resistant.

The Clinical Trials

The approval of Epidiolex was based on multiple rigorous clinical trials that met the highest standards of medical evidence:

Randomized, double-blind, placebo-controlled design: These trials compared Epidiolex to placebo in patients who were already taking other anti-seizure medications without adequate seizure control. Neither the patients nor the researchers knew who was receiving the real medication.
Significant seizure reduction: In trials for Dravet syndrome, patients taking Epidiolex experienced a median reduction in convulsive seizure frequency of approximately 39%, compared to 13% in the placebo group. For LGS, drop seizures were reduced by 37–42% compared to 17–19% with placebo.
Meaningful clinical improvement: Beyond raw seizure counts, caregivers and clinicians reported overall improvement in condition severity for a significantly higher proportion of patients on Epidiolex compared to placebo.
Long-term data: Open-label extension studies have shown that the seizure-reducing effects of Epidiolex are maintained over years of continued use, with some patients experiencing further improvement over time.

Key takeaway: Epidiolex is not a folk remedy or an unproven supplement. It is an FDA-approved medication that went through the same rigorous approval process as any other pharmaceutical drug. For families dealing with severe, treatment-resistant epilepsy, it has been genuinely transformative.

How Epidiolex Works

The exact mechanism by which CBD reduces seizures is not fully understood, but research points to several pathways:

Modulation of neuronal excitability: CBD appears to reduce the excessive electrical activity that causes seizures by interacting with multiple molecular targets in the brain, including ion channels that regulate how neurons fire.
GPR55 receptor antagonism: CBD blocks GPR55, a receptor that when activated increases neuronal excitability. By blocking this receptor, CBD may help prevent the cascade of overexcitation that leads to a seizure.
TRPV1 channel activation: CBD activates TRPV1 channels, which can desensitize neurons and reduce their tendency to fire excessively.
Adenosine reuptake inhibition: CBD may increase levels of adenosine, a naturally occurring compound in the brain that has anti-seizure properties.

Notably, CBD's anti-seizure effects do not appear to work primarily through the CB1 and CB2 cannabinoid receptors that are central to most other cannabis effects. This is part of why CBD can reduce seizures without producing the psychoactive effects associated with THC.

Beyond Epidiolex: Other Cannabis-Based Approaches

While Epidiolex is the gold standard, some patients and families have explored other cannabis-based approaches for seizure management:

Full-spectrum CBD products: Some patients report better seizure control with full-spectrum extracts (containing small amounts of other cannabinoids and terpenes) compared to pure CBD, possibly due to the entourage effect. However, these products are not FDA-approved for epilepsy, and their quality and consistency can vary significantly.
THC-containing products: There is limited evidence that small amounts of THC may enhance CBD's anti-seizure effects in some patients, but THC can also lower the seizure threshold in others. This is an area that requires extreme caution and medical supervision.

How People Use Cannabis for Epilepsy

Cannabis use for epilepsy differs substantially from its use for other conditions covered on this site, because there is an FDA-approved, prescription-only medication available.

Epidiolex (prescription): The most evidence-backed approach. Prescribed by a neurologist, typically as an add-on therapy to existing anti-seizure medications. Dosing is carefully calibrated by the prescribing physician based on the patient's weight and response.
Over-the-counter CBD products: Some patients use commercially available CBD products, but these are not equivalent to Epidiolex. They may have inconsistent CBD concentrations, may contain undisclosed THC, and are not subject to pharmaceutical-grade quality controls.
State medical cannabis programs: In many states, epilepsy is a qualifying condition for medical cannabis programs. Some patients access cannabis products through these programs, particularly when Epidiolex is not affordable or available.

Recommended Starting Points

Epilepsy management with cannabis should always be done under the direct supervision of a neurologist or epileptologist. This is not a condition for self-experimentation.

Talk to your neurologist first. If you or a family member has treatment-resistant epilepsy, ask your neurologist specifically about Epidiolex. They can evaluate whether it is appropriate based on the specific epilepsy syndrome, current medications, and overall health.
Epidiolex is the first choice. Because it is FDA-approved, pharmaceutical-grade, precisely dosed, and backed by clinical trial evidence, Epidiolex should be the first cannabis-based option considered for seizure management.
Do not substitute OTC CBD for Epidiolex. Over-the-counter CBD products are not interchangeable with Epidiolex. Their inconsistent potency and purity make them unreliable for a condition as serious as epilepsy.
Never adjust anti-seizure medications on your own. Adding any cannabis product to an existing anti-seizure regimen must be done under medical supervision due to significant drug interaction potential (see below).

Risks & Considerations

Drug Interactions with Anti-Seizure Medications

This is critically important. CBD interacts with the liver's CYP450 enzyme system and can significantly affect the levels of other medications in your body. For epilepsy patients, the most notable interactions include:

Clobazam: CBD inhibits the enzyme CYP2C19, which metabolizes clobazam (a benzodiazepine commonly used in epilepsy). This can cause clobazam levels to rise substantially, leading to increased sedation and other side effects. In clinical trials, the most common side effect reported with Epidiolex was somnolence (drowsiness), often related to this interaction. Clobazam doses frequently need to be reduced when Epidiolex is added.
Valproate: The combination of CBD and valproate has been associated with elevated liver enzymes (a marker of liver stress). Patients on both medications require regular liver function monitoring, particularly in the early months of treatment.
Other anti-seizure medications: CBD can interact with many other anti-seizure drugs through various CYP450 pathways. Your neurologist will need to monitor drug levels and potentially adjust doses.

Side Effects of Epidiolex

In clinical trials, the most commonly reported side effects included:

Somnolence (drowsiness) and sedation
Decreased appetite
Diarrhea
Elevated liver enzymes (transaminases)
Fatigue and malaise
Infections (upper respiratory)

Most side effects were dose-dependent and manageable with dose adjustments. Liver function tests are required before starting Epidiolex and at regular intervals during treatment.

Additional Cautions

Never stop anti-seizure medications abruptly. Suddenly discontinuing anti-seizure medications can trigger breakthrough seizures, including status epilepticus (a medical emergency). Any medication changes must be made gradually under medical supervision.
THC may lower seizure threshold. While CBD has anti-seizure properties, THC has a more complex relationship with seizures. Some evidence suggests THC can lower the seizure threshold in some individuals. THC-containing products should be used with extreme caution, if at all, in people with epilepsy.
Quality and consistency matter enormously. For a condition as serious as epilepsy, the quality control that comes with an FDA-approved medication is not optional. Variable potency in non-pharmaceutical products could mean the difference between seizure control and a breakthrough seizure.

Key takeaway: Epilepsy is the one condition where the cannabis research story is clear and strong. But that strength applies specifically to pharmaceutical-grade, purified CBD (Epidiolex) used under medical supervision — not to self-directed use of dispensary products. The drug interaction potential with other seizure medications makes professional oversight essential.

Talk to Your Doctor

If you or a family member has epilepsy, your neurologist should be your primary resource. Here are some ways to start the conversation:

Conversation starters:

"We've tried [number] medications and are still having [frequency] seizures. Can we discuss whether Epidiolex might be an option?"
"I've been reading about CBD for epilepsy and I understand there's an FDA-approved medication. Could you tell me whether it's appropriate for my/my child's specific epilepsy syndrome?"
"I want to make sure I understand how CBD might interact with the medications we're already taking."

Cost considerations: Epidiolex can be expensive, particularly without insurance coverage. The manufacturer offers a patient assistance program, and your neurologist's office may be able to help navigate insurance authorization. Some patients have explored state medical cannabis programs as a more affordable alternative, though this comes with trade-offs in product standardization and quality control.

For finding epilepsy specialists experienced with cannabinoid therapies, the Epilepsy Foundation and the Society of Cannabis Clinicians are good starting points.

Are You 21 or Older?

Cannabis for Epilepsy & Seizures